ARCHIVES

Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

First Formal CREG Guidelines, Rules Publishes

June 6, 1975

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006